NeuroMetrix Disappoints
Stock quotes in this article:
NURO
With Tuesday's quarterly update, NueroMetrix (NURO Quote) failed to calm investors' nerves.
For starters, the marketer of controversial nerve studies missed Wall Street expectations by a large measure. The company's first-quarter revenue, stuck at last year's level of $11.8 million, fell shy of the $13 million consensus estimate. Moreover, the company's net loss of $1.4 million, or 11 cents a share, came in 10 times higher than a year ago. Analysts had been hoping for a modest profit instead. Shares of NeuroMetrix slid 4.6% to $9.66 on the news. Still, NeuroMetrix signaled that better times could be on the way. Notably, the company stated that a regional Medicare carrier has issued a favorable reimbursement decision about nerve tests performed by its NC-stat devices. Specifically, the company said that First Coast Service Options will allow healthcare providers to again start billing for NC-stat tests using "traditional nerve conduction codes" -- meant for intensive tests triggering lucrative payments -- rather than problematic miscellaneous codes. Some other insurers now insist on miscellaneous codes, demanding heavy documentation with no guarantees on reimbursement, for NC-stat studies instead. "Several commercial payers, including certain Blue Cross Blue Shield regional carriers, have taken unfavorable positions toward the NC-stat, referring to it as experimental and investigational," NeuroMetrix CEO Shai Gozani said Tuesday. "On the other hand ... FCSO has appropriately determined that the issue of nerve conduction is a matter for the American Medical Association. "We view this as a very positive development for our customers and for NeuroMetrix."- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,337.05 | 1,095.94 | 2,183.73 | 34.23 |
Oil *
72.45
|
|
UP
51.08
|
UP
4.01
|
UP
10.74
|
UP
0.31
|
10 Yr
3.42%
SPDR Gold
110.84
|
|
+0.50%
|
+0.37%
|
+0.49%
|
+0.91%
|
Data delayed 20 minutes |














